Looking for a stock that might be in a good position to beat earnings at its next report? Consider Aetna Inc (AET - Free Report) , a firm in the Medical Health Maintenance Organizaton industry, which could be a great candidate for another beat.
This company has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. In fact, in these reports, AET has beaten estimates by at least 10% in both cases, suggesting it has a nice short-term history of crushing expectations.
Earnings in Focus
Two quarters ago, AET expected to post earnings of $2.36 per share, while it actually produced earnings of $2.71 per share, a beat of 14.8%. Meanwhile, for the most recent quarter, the company looked to deliver earnings of $2.34 per share, when it actually delivered earnings of $3.42 per share, representing 46.1% positive surprise.
Aetna Inc. Price and EPS Surprise
Thanks in part to this history, recent estimates have been moving higher for Aetna. In fact, the Earnings ESP for AET is positive, which is a great sign of a coming beat.
After all, the Zacks Earnings ESP compares the most accurate estimate to the broad consensus, looking to find stocks that have seen big revisions as of late, suggesting that analysts have recently become more bullish on the company’s earnings prospects. This is the case for AET, as the firm currently has a Zacks Earnings ESP of +1.34%, so another beat could be around the corner.
This is particularly true when you consider that AET has a great Zacks Rank #2 (Buy) which can be a harbinger of outperformance and a signal for a strong earnings profile. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
When you add this solid Zacks Rank to a positive Earnings ESP, a positive earnings surprise happens nearly 70% of the time, so it seems pretty likely that AET could see another beat at its next report, especially if recent trends are any guide.
5 Trades Could Profit ""Big-League"" from Trump Policies
If the stocks above spark your interest, wait until you look into companies primed to make substantial gains from Washington's changing course.
Today Zacks reveals 5 tickers that could benefit from new trends like streamlined drug approvals, tariffs, lower taxes, higher interest rates, and spending surges in defense and infrastructure.
See these buy recommendations now >>